Endo International Stock Analysis (NASDAQ:ENDP)

Add to My Stocks
$9.97 $0.02 (0.2%) ENDP stock closing price Mar 24, 2017 (Closing)
Watch Robo Advisor Video of ENDP Stock Analysis
Endo International
Updated on : Mar 24, 2017
previous close
ENDP 10 (0%)
S&P 500 2344 (0%)
Closing Price On: Mar 24, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q4
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-86.6%
Sector Average:
-6.4%
5 Quarter Net Profit
Net Margins
2016-Q4
%
LTM Margin
Debt/Equity Ratio
Debt:
8.27B
Debt/Equity Ratio:
 3.06
Compared to the industry
Cash Flow
Operating cash flow:
$81.1M
Net Income:
-$3.34B
PROS      CONS
Recent Growth
PE Valuation
PS Valuation
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
ENDP PS :
0.6
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-21.1%
Return on Equity:
-62.2%
Free Cash Flow Margin:
2.8%
Double Tap To Exit Full Screen
0:00
/

Endo International Analysis Video

265 6 2

View Endo International stock analysis video. This is our ENDP analyst opinion covering the buy and sell arguments for ENDP stock.

Endo International plc - Ordinary Shares Stock Rating (2.6/5)

Our Endo International stock opinion is based on fundamentals of the company. This Endo International stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy ENDP stock?

  • Endo International sales grew by 15.6% year on year in 2016 Q4.
  • The price to earnings multiple of 2.1 is attractive when compared with the industry average PE ratio of 21.
  • The lower PS ratio 0.6 for ENDP stock versus Medical-Drugs industry average of 4.7 is a positive for the company.

Should you sell ENDP stock?

  • Endo International registered a negative operating margin of -86.6% (average) over the Trailing Twelve Months (TTM).
  • Over the last 12 months, Endo International had an average Net loss of -83.5%.
  • Endo International has a debt/equity ratio of  3.06, which is worse than the average in the Medical sector.
  • Endo International has a negative ROIC (Return on Invested Capital) of -21.1%.
  • A negative ROE of -62.2% indicates that the company is not able to generate profits with the money shareholders have invested.

Comments on this video and Endo International stock